contents were lavaged with phosphate-buffered saline with gentle massage (3) .
The lavage fluid from a single rat was sedimented at 3,000 x g for 15 min at 4°C, and the entire pellet was suspended in 35 to 40 ml of Dulbecco modified Eagle medium-5% calf serum-cefotaxime (100 ,ug/ml)-amikacin (100 p.g/ml) (tissue * Corresponding author. culture medium; TCM). Murine ascites fluid containing monoclonal antibody to the rat common leukocyte antigen (anti-CLA; 50 ,u) (catalog no. 15708-1; Pelfreeze Biologicals, Rogers, Ark.) was added, and the suspension was gently mixed. After incubation on a tilt table, the material was sedimented at 1,500 x g at 4°C for 10 min. The pellet was suspended in fresh TCM and vigorously vortexed, and centrifugation at 1,500 x g was repeated. At each step, the aggregated macrophages and polymorphonuclear leukocytes were pelleted, while P. carinii was sedimented much less efficiently. When the aim of the procedure was recovery of as many P. carinii cells as possible, this was repeated two to three times, and the recovery of P. carinii in the supernatant fluid was monitored by light microscopy. After each centrifugation at 1,500 x g, the supernatant fluid containing P. carinii was decanted, to be subsequently centrifuged at 3,000 x g for 15 min at 4°C to pellet the organisms. In additional experiments, we evaluated the relative efficiencies of antibody alone, antibody plus rat complement (Sigma Chemical Co., St. Louis, Mo.), and incubation at 37 and 4°C on separation of P. carinii from host cells, in an effort to define the least cumbersome method of separation.
The results of this method of separation of P. carinii from cellular elements of lung lavage material are shown in Fig. 1 . The lavage fluid from the animal contained >2 x 106 polymorphonuclear leukocytes per ml (45-ml total volume), secondary to superinfection with gram-negtive bacteria before treatment with anti-CLA (Fig. 1A) . After exposure to anti-CLA and centrifugation (Fig. 1B) , <200 polymorphonuclear leukocytes per ml remained suspended (40-ml total volume). P. carinii is identified only with difficulty in the untreated lavage fluid (Fig. 1A) 1 . Samples of bronchoalveolar lavage material taken from rat with steroid-induced P. carinii pneumonia before (A) and after (B) treatment of the fluid with anti-CLA. For these photomicrographs, the samples were brought to equal volumes (45 ml), and 10-pul samples were spotted onto acetone-cleaned glass slides, allowed to air dry, and stained with Diff-Quik stain. Before treatment of the lavage fluid with anti-CLA (A), P. carinii cells were detected only with difficulty, with the organisms shown in this micrograph representing some of the most distinct examples. In such preparations containing large numbers of intact and degenerated phagocytes, identification of P. carinii is difficult unless the encysted forms (.) can be found. Trophozoites ( 0 ), although present, are difficult to distinguish from inflammatory cell structures. After treatment of the fluid with anti-CLA (B), the supernatant fluid contains no intact phagocytes, and numerous trophozoites ( ) (only five have been marked; most of the material in the field, at different planes of focus, is also P. carinii), as well as encysted forms (), are visible. The magnification for both micrographs is identical; the bar at the lower right corner of panel A represents 10 pLm. The x 100 objective was used.
as possible by exposure to toxic secretory products of phagocytes (2) .
Although these experiments were conducted as a part of an ongoing effort to study rat P. carinii, it seems likely that, with slight modification, similar reagents (e.g., monoclonal antibody to human myeloid-histiocyte antigen; Dako Corp., Santa Barbara, Calif.) could be useful in studies of human P. carinii pneumonia. Concentration of P. carinii to small volumes after elimination of most host cells from the sample could allow diagnostic evaluation of a bronchoalveolar lavage sample to be performed rapidly with simple, rapid stains, such as the Diff-Quik stain, which allow recognition of all phases of P. carinii. This method may also permit more in vitro studies of human P. carinii.
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